Bitcoin Breaks Above 19,000
Bitcoin rally continues for the twelfth consecutive day breaking above the 19,000 mark for the first time since November 8 2022
GBPUSD Pushes Higher on Economic Data
GBPUSD trades higher on better-than-expected economic data released earlier today. The UK economy expanded by 0.1% in November 2022 well above the forecasts for a 0.2% contraction.
Silvergate Capital (SI) Slumps 43% on Massive Withdrawals
Silvergate Capital (SI) stocks plunge 40% after huge client withdrawals were revealed in the Q4 preliminary metrics results.
EURUSD Down 130 Pips on Strong DXY
EURUSD slumps in early European trading as traders return to their offices after the New Year festivities. EURUSD is down 1.11% at 1.0546 hitting the lowest level since December 13
Key Events in the Week Ahead 2/8-1-2023
Investors looking for a better year after a disaster for many assets in 2022. You can read How Markets Performed in 2022. On Monday stock and bond markets will be closed
How Markets Performed in 2022
A tough year for investors across all asset classes and around the globe was 2022 as negative returns prevailed. Persisting inflation was the main theme globally which pushed all major central banks to aggressive rate hikes
Tesla (TSLA) Hits Extreme Oversold Levels
Tesla (TSLA) stock continue the slide for the seventh consecutive trading session hitting the lowest level since August 18, 2020. Sell-off in the technology sector continues and the Nasdaq index is 1.10%
FedEx (FDX) Third Quarter Earnings
FedEx reported the fiscak second quarter earnings for the three months ending September 30. FDX beat on earnings but missed on revenues;
Nikkei 225 Slumps After BOJ Surprise Move
Nikkei 225 and Asian istocks slide on Tuesday after the Bank of Japan adjusted its yield curve control (YCC) program increasing the allowable band for 10-year bond yields to target a band in and around 0.50% from the previous band of 0.25%.
Madrigal Stock Skyrockets after Positive Topline Results from MAESTRO-NASH Clinical Trial
Madrigal Pharmaceuticals (MDGL) finished the trading session today 268.07% higher at $234.83 after unexpected positive topline results from the Pivotal Phase 3 MAESTRO-NASH Clinical Trial of its drug Resmetirom
Latest Posts
